Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the previous study content with an access-denied screen. The page no longer displays details about the study.SummaryDifference18%

- Check21 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a page update. The FRUTIGA study record content remains unchanged.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page revision label was updated to v3.6.6, reflecting a new metadata revision; content and study details appear unchanged.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows Revision: v3.6.5, updating the site's version tag from v3.6.4. This is a platform-level update and does not alter the study details or other user-facing content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous revision tag and signaling a minor update to the page’s revision history.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a new version of the page. This typically reflects minor edits or maintenance without altering the study details visible to users.SummaryDifference0.1%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.